Biotechnology

NeuroVision acquires Durin Life Sciences to improve brain disease diagnosis

Argenx confirms Karen Massey as new Chief Executive following annual meeting

ScreenPoint Medical secures 13.6 million euros to advance breast cancer AI technology

Jeito Capital secures record $1.2 billion to drive biopharma innovation

Professor Victoria Cogger named founding head of Sydney Biomedical Accelerator

Samsung Next backs Nucleus Genomics in strategic investment move

Harbour BioMed signs long-term deal with Lannacheng to advance new radionuclide cancer therapies

Women in Entrepreneurship Series: Dr. Maria Chatzou Dunford- Founder and CEO at Lifebit

The rise of the UK’s Femtech market and emerging trends

PHASE Scientific raises $34m to advance non-invasive diagnostics for Women’s health